A · Important
[C Sinovac rose more than 57%, triggering a second temporary stop] On September 18, near-end new stocks continued to heat up in the afternoon, and C Sinovac expanded its gains to 57%, triggering a second temporary stop. According to the data, the company is an innovative drug company that is disease-oriented and focuses on major unmet clinical needs.
Comments